drugset

drugset / Trial / NCT00200460

A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients

NCT00200460 ↗

Phase 3 Completed 825 enrolled Mylan Bertek Pharmaceuticals

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effects of various doses of nebivolol in patients with mild to moderate hypertension.

Timeline

Start: 2001-09
Primary completion: —
Completion: 2003-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Nebivolol	Other / unclassified	—	—

Indications